ACR246
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACR246, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors [Phase 1]